Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Cohort Study of Treatment Patterns and Outcomes in Patients With HER2 Positive (HER2+) Metastatic Breast Cancer (SystHERs Registry (Systemic Therapies for HER2+ Metastatic Breast Cancer Study)).

NCT01615068 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01615068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01615068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Cohort Study of Treatment Patterns and Outcomes in Patients With HER2 Positive (HER2+) Metastatic Breast Cancer (SystHERs Registry (Systemic Therapies for HER2+ Metastatic Breast Cancer Study)).
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Completed
Start date
June 5, 2012
Completion date
November 16, 2017
Enrollment
1,007 (actual)
Sites
142

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer